A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects.More than ...

A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid medications, according to a new ...

Nektar Therapeutics (NKTR) showcases financial resilience and advances in its ResPEG program, despite facing market ...

Just a third of health staff had the flu jab last year, leading to fears that vulnerable patients will catch the virus in ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

This Comment is an urgent global call to action. I, as a pulmonologist, have concerns regarding the impacts of environmental ...

Enanta Pharmaceuticals, Inc.'s strong pipeline, positive RSV drug data, and solid cash position drive growth. Click for my ...

The approval marks the first for a targeted treatment in chronic spontaneous urticaria in Europe in over a decad ...

As the US Centers for Medicare and Medicaid Services (CMS) has released the new prices for 15 drugs that have been added to ...

How drugs were selected: Drugs were selected earlier this year based on criteria written into the law. They had to have no ...

Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both ...

Adventist Health White Memorial says it is taking steps to reaffirm its commitment to patient privacy in the face of ICE ...